Sponsor or institution
Clinical trials and research at The Second Affiliated Hospital of Chongqing Medical University
As of November 12, 2026, Find a Trial lists 18 clinical trials run by The Second Affiliated Hospital of Chongqing Medical University that are recruiting, in China. By phase: Phase 2 (4), Phase 4 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 1Country
Newest trials
All recruiting trials (18)
-
Sequential combination therapy for functional cure of chronic hepatitis B
This trial tests a new two-drug approach to see if adding immunotherapy to ongoing HBV treatment can lead to loss of hepatitis B surface antigen in adults with chronic hepatitis B.
-
Combination therapy for functional cure in chronic hepatitis B
This phase 2 trial tests whether a sequence of anti-PD-1/PD-L1 antibodies with pegylated interferon and nucleos(t)ide analogues can achieve functional cure (HBsAg loss) in adults with chronic hepatitis B.
-
ASC22 plus pegylated interferon alfa to try to achieve a functional cure for chronic hepatitis B
This trial tests whether adding ASC22 (an anti–PD‑L1 antibody) to pegylated interferon alfa with background antiviral pills can help adults with HBeAg‑negative chronic hepatitis B and very low viral markers reach a functional cure.
-
Underdilated stent technique to reduce encephalopathy after TIPS
This trial tries to see if using an underdilated stent (smaller balloon dilation before placing a standard covered stent) during TIPS lowers the chance of hepatic encephalopathy for people with cirrhosis who need TIPS for variceal bleeding or refractory ascites.
-
4DCT-guided functional lung avoidance radiotherapy to spare high-function lung
This study will test whether using 4DCT-derived lung ventilation maps to guide radiotherapy can better spare high-function lung in adults receiving thoracic IMRT or SBRT for lung cancer.
-
Stepwise strategy to treat atrial fibrillation–related left atrial remodeling
Researchers will test whether sacubitril/valsartan can lower AF recurrence and improve left atrial structure and function in adults 18–80 with persistent atrial fibrillation and modest left atrial enlargement who undergo cardioversion and possible ablation.
-
A prognostic model that adds nutritional and metabolic measures for liver cirrhosis
This project will test whether adding objective nutritional measurements and metabolic profiles to routine clinical data can better predict outcomes for adults with liver cirrhosis.
-
Investigating how serum calcium levels affect pain after abdominal surgery
This study is testing if changes in calcium levels in the blood can affect how much pain people feel after having abdominal surgery.
-
Cooling the skin to reduce pain from arterial puncture
This study is testing if cooling the skin can help reduce pain during arterial punctures for people who need this medical procedure.
-
Using Coenzyme Q10 to Reduce Pain After Lung Surgery
This study is testing if Coenzyme Q10 can help reduce pain after lung surgery for adults aged 18-75.
-
Using liposomal bupivacaine for pain relief after lung surgery
This study is testing whether a new form of pain relief called liposomal bupivacaine can help people manage pain better after lung surgery compared to the standard treatment.
-
Exploring how nutrition affects liver cirrhosis prognosis
This study looks at how nutrition affects the health and survival of people with liver cirrhosis to see if better eating can improve their outcomes.
-
Using sulfasalazine to treat liver fibrosis and cirrhosis.
This study is testing if the medication sulfasalazine can help improve liver function and health in people with different types of cirrhosis.
-
Prenatal prevention and treatment strategy for neonatal ARDS
We will test whether giving antenatal corticosteroids to pregnant women who are predicted to be at high risk of neonatal ARDS can reduce newborn lung fluid problems, ARDS severity, and death.
-
High-dose Cyclophosphamide treatment for adult patients with Hemophagocytic Syndrome
This study is testing if high doses of Cyclophosphamide can help adults with Hemophagocytic Syndrome get better and live longer.
-
How nutritional measures relate to COVID-19 outcomes
This will see if common nutrition measures (like prognostic nutritional index, geriatric nutritional risk index, BMI, and pectoralis muscle index) predict recovery or worsening in adults with COVID-19 treated at a hospital in Chongqing.
-
Combination of peg‑IFNα and an anti‑PD‑1 antibody plus antiviral therapy to try to cure chronic hepatitis B
This phase 2 test will try adding an anti‑PD‑1 antibody to peg‑IFNα and nucleos(t)ide therapy to see if it produces sustained HBsAg loss in adults with chronic hepatitis B.
-
Anti‑PD‑1 plus antivirals and interferon to try for sustained HBsAg loss in chronic hepatitis B
This trial will try adding an anti‑PD‑1 antibody to standard nucleos(t)ide antivirals (with sequential interferon in some patients) to see if more adults with chronic hepatitis B can achieve sustained HBsAg loss.
Quick answers
How many clinical trials run by The Second Affiliated Hospital of Chongqing Medical University are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.